Abby Timmons is an associate in the Orange County office of Latham & Watkins and a member of the Corporate Department.

Abby represents both public and private companies, particularly in the REIT, life sciences, and technology industries. She advises clients across a broad range of corporate transactions, including mergers and acquisitions, capital markets transactions, and general corporate matters.

In addition to her commercial work, Abby maintains a pro bono practice and serves on Latham’s Associates Committee. She also previously served on the Training and Career Enhancement (TACE) Committee, supporting the firmwide training program, Latham & Watkins University. From 2021 to 2022, she served as a judicial clerk to Vice Chancellor Sam Glasscock III of the Delaware Court of Chancery.

Abby’s representative experience, with an emphasis on mergers and acquisitions work, includes advising on the following transactions:

  • Sun Communities, Inc. in its US$5.65 billion sale of its Safe Harbor Marinas business to Blackstone Infrastructure
  • Nevro Corp. in its sale to Globus Medical
  • Golden State Enterprises, Inc. in its sale of a controlling interest in Golden State Foods to Lindsay Goldberg
  • Skydance Media, LLC in its pending US$28 billion merger with Paramount Global
  • Amphenol Corporation in its US$2.025 billion acquisition of the Carlisle Interconnect Technologies business segment
  • Amphenol Corporation in its US$140 million acquisition of PCTEL, Inc.
  • CoStar Group, Inc. in its pending US$2.1 billion acquisition of Matterport, Inc.
  • Realty Income Corporation in connection with capital markets matters relating to its acquisition of Spirit Realty Capital, Inc.
  • Icosavax, Inc. in its US$1.1 billion sale to AstraZeneca plc
  • Nevro Corp. in its US$40 million acquisition of Vyrsa Technologies
  • Convex Labs in its sale to ServiceTitan
  • INDUS Realty Trust, Inc. in its US$868 million acquisition by Centerbridge and GIC
  • Hersha Hospitality Trust in connection with capital markets matters relating to its US$1.4 billion acquisition by KSL Capital Partners
  • Prometheus Biosciences, Inc. in its US$10.8 billion acquisition by Merck & Co., Inc.
  • Ouster, Inc. in its US$400 million merger of equals with Velodyne Lidar, Inc.
  • AEON Biopharma, Inc. in connection with capital markets matters relating to its business combination with Priveterra Acquisition Corp.
  • Ouster, Inc. in its US$1.9 billion business combination with Colonnade Acquisition Corp.
  • Planet Labs in its US$2.8 billion business combination with dMY Technology Group, Inc. IV
  • Realty Income Corporation in its acquisition of VEREIT, Inc.
  • The underwriters in the initial public offering of Intapp, Inc.
  • Numerous follow-on offerings for public companies, especially in the REIT and life sciences industries

Bar Qualification

  • California

Education

  • JD, Notre Dame Law School, 2019
    summa cum laude
  • BA in Professional Writing, Purdue University, 2016

Languages Spoken

  • English